USPTO Pulls Plug on Speedy Green Tech Patent Program
Published Date: 4/18/2025
Notice
Summary
The USPTO is ending the Climate Change Mitigation Pilot Program, which helped certain patent applicants speed up their reviews if their inventions fight climate change. This change affects anyone using the program and means no new applications will be accepted after the termination date. If you’re in the program, keep an eye on deadlines to wrap things up smoothly—no extra fees or delays expected!
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
No New Climate Pilot Applications
The USPTO is terminating the Climate Change Mitigation Pilot Program, and no new applications will be accepted after the program's termination date. If you were planning to use the program to get faster patent review for a climate-related invention, you will not be able to submit new requests under this pilot.
Current Participants Should Finish Filings
If you are already using the Climate Change Mitigation Pilot Program, watch your existing deadlines so you can finish your filings before the program ends. The notice says participants should wrap things up smoothly and that no extra fees or delays are expected for those already in the program.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16744, Request for Comments on Community Outreach Office Locations in the Southwest States
The USPTO wants your ideas on where to open new community outreach offices in the Southwest states like Arizona and Texas. These offices will help inventors, small businesses, and students get better support with patents. Share your thoughts by September 16, 2026, so the USPTO can pick the best spots and keep innovation booming without extra costs to you!
2026-16315, Administrative Updates to the General Requirements Bulletin for Admission to the Examination for Registration To Practice in Patent Cases Before the United States Patent and Trademark Office
Starting August 11, 2026, the USPTO is upgrading Biomedical Science degrees from Category B to Category A for patent bar eligibility. This means more people with this degree can now take the patent exam and become patent practitioners. No extra fees or delays—just a smoother path for those with the right science background to join the patent world!
2026-14939, Grant of Interim Extension of the Term of U.S. Patent No. 8,877,798; Centanafadine Hydrochloride
Otsuka America Pharmaceutical got a one-year extra patent life for their drug centanafadine hydrochloride because the FDA review is still going on. This means their patent, which was set to expire on July 25, 2026, now lasts until July 25, 2027. This extension helps Otsuka keep exclusive rights to their drug a bit longer while waiting for final FDA approval.
2026-14941, Grant of Interim Extension of the Term of U.S. Patent No. 8,461,196; Centanafadine Hydrochloride
Otsuka America Pharmaceutical got a one-year extra patent life for their drug centanafadine hydrochloride because the FDA review is still going on. This means they keep exclusive rights to the drug until July 25, 2027, giving them more time to sell it without competition. This extension helps the company protect their investment while the drug gets final approval.
2026-14793, Requirement To Identify All Real Parties in Interest to a Third Party Request for an Ex Parte Reexamination
The USPTO wants anyone asking for a third-party ex parte reexamination to clearly say who’s really behind the request. This helps stop sneaky tricks and keeps the process honest. If you’re involved, get ready to share this info confidentially by August 21, 2026, or risk delays or issues.
2026-14388, Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Admission to Practice and Roster of Registered Patent Attorneys and Agents Admitted to Practice Before the United States Patent and Trademark Office
The USPTO is asking for public feedback on its paperwork rules for patent attorneys and agents who want to practice before the office. This helps keep the process smooth and fair without making people fill out too many forms. If you have thoughts, send them in by August 17, 2026—no fees or big changes are happening right now, just a review.
Previous / Next Documents
Previous: 2025-06700, Change in Bank Control Notices; Acquisitions of Shares of a Bank or Bank Holding Company
If you want to buy or control a bank or bank holding company, you need to tell the Federal Reserve and wait for their okay. People affected include anyone trying to buy big shares in banks, and they have until May 5, 2025, to send comments or objections. This keeps bank ownership clear and fair, with no surprise takeovers or secret deals!
Next: 2025-06702, Curtiss-Wright Corporation; Export License Application
Curtiss-Wright Corporation wants permission to send special reactor pumps and parts to China. The U.S. Nuclear Regulatory Commission is reviewing this request and inviting the public to share their thoughts or ask for a hearing. This decision could affect international trade and nuclear tech exports soon.